How do you decide if a full-time CRO is right for a PE-backed company when board wants a revenue turnaround?

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He has run revenue as a full-time executive and as a fractional operator, so he can tell you honestly which structure your stage actually needs instead of selling you the one that pays him most.

👉 See Kory White on LinkedIn

The Board-Level Buying Dynamic in a PE Turnaround

The buying committee for a full-time CRO in a PE-backed turnaround is not the company’s executive team; it is the board, specifically the operating partner, the deal lead, and often a senior advisor from the PE firm’s value-creation group. The typical deal size here is not a revenue number but a compensation package: a base salary of $250,000 to $400,000, a significant at-risk bonus tied to EBITDA or net revenue retention, and equity that vests over three to five years, often with a clawback if the turnaround fails within the first two years. Budget approval happens through the PE firm’s quarterly portfolio review, not the company’s annual planning cycle, meaning the CRO’s compensation must be justified against the fund’s internal rate of return targets, not the company’s standalone profitability.

What the buyer evaluates is not the candidate’s industry expertise but their track record of compressing sales cycles in distressed environments. The PE operating partner will scrutinize whether the candidate has ever managed a sales force where the product’s core value proposition had eroded, or where the customer base was churning at over 30% annually. Deals stall here because the board cannot agree on whether the turnaround requires a product pivot or a sales process overhaul. If the board believes the problem is execution, they will push for a full-time CRO with a mandate to replace the VP of Sales. If they believe the problem is market fit, they will push for a fractional CRO who can advise the CEO on product-led growth while the CEO retains control of the sales team.

Sales-Cycle Implications Under Board Pressure

The motion forced by a PE-backed turnaround is a "hunt and harvest" hybrid that few CROs execute well. The team must simultaneously close new logos to show the board immediate pipeline growth (hunt) while extracting maximum value from the existing customer base to stabilize revenue (harvest). The ramp for a new CRO here is four to six months, but the board expects visible improvement in pipeline velocity within eight weeks. This creates a dangerous forecast behavior: the CRO will over-index on discounting to close deals in the first quarter, which temporarily inflates bookings but destroys net revenue retention and creates a churn wave six months later.

Pipeline shape becomes inverted. Normally, a healthy pipeline has 60% of value in early-stage opportunities and 20% in late-stage. In a PE turnaround, the pipeline is heavily weighted toward late-stage deals that are at risk of falling out, because the sales team has been discounting to keep the board happy. The leaks are not in prospecting or qualification; they are in the negotiation phase, where buyers sense the company’s desperation and demand deeper discounts or longer payment terms. The typical deal size shrinks by 20-30% in the first two quarters as the CRO prioritizes cash over margin. The buying committee for each deal shifts from internal champions to procurement officers who know the company is under PE pressure and will exploit that knowledge.

What a Fractional or Interim Revenue Leader Looks Like Here

A fractional or interim CRO in a PE-backed turnaround operates with a 90-day contract, a fixed fee of $15,000 to $25,000 per month, and zero equity. Their first 30 days are spent auditing the sales process, the CRM data quality, and the compensation plan. They do not fire anyone in the first 60 days unless there is clear evidence of fraud or incompetence. Their operating cadence is weekly board calls, not daily standups. They own the pipeline review and the forecast, but they advise the CEO on whether to restructure the sales team or replace the VP of Sales. The signal to convert to full-time is when the interim leader identifies that the turnaround requires a fundamental change in the sales compensation model or a new go-to-market motion that will take 12 months to implement. If the problem can be solved with a process fix and a pricing adjustment, the interim leader can exit after 90 days.

A full-time CRO in this context looks different. They demand a 12-month minimum commitment, a board seat, and the authority to replace the VP of Sales and the Customer Success leader within the first 90 days. Their first 90 days are not about discovery; they are about firing low performers, renegotiating the compensation plan to reduce base salaries and increase variable pay, and forcing the sales team to focus on a single vertical or use case. They own the entire revenue operation, including marketing and customer success, not just sales. They advise the board on whether the company needs to raise a bridge round to fund the turnaround, because the CRO knows that a full-time role without adequate working capital is a suicide mission.

The Board’s Decision Framework: Full-Time vs. Interim

The board’s decision is driven by two variables: the company’s cash runway and the CEO’s ability to manage the sales force. If the company has less than 12 months of cash runway, a full-time CRO is a mistake because the executive will spend half their time fundraising, not selling. The board should hire a fractional CRO who can stabilize revenue while the CEO raises capital. If the company has more than 18 months of runway but the CEO is hands-on in sales, a full-time CRO creates conflict because the CEO will undermine the CRO’s authority. The board should hire an interim CRO who reports to the CEO but has a direct line to the board, so the CEO cannot fire them without board approval.

The specific signal to go full-time is when the board realizes that the turnaround requires a new sales compensation model that will take 12 months to implement and another 12 months to see results. A fractional leader cannot commit to that timeline because they are juggling multiple clients. The board must also assess whether the company’s sales cycle is longer than 90 days. If the average deal cycle is 120 days, a fractional CRO will leave before the pipeline they build converts. A full-time CRO is needed to see the pipeline through to close. However, if the company’s sales cycle is under 60 days, a fractional CRO can fix the process and exit within the contract period, and the board should not pay the premium for a full-time executive.

The Operating Cadence Difference

A fractional CRO in a PE turnaround operates on a "diagnose and delegate" cadence. They spend 10 hours per week on the client, with two hours in pipeline reviews, two hours in board meetings, and six hours in individual coaching sessions with the VP of Sales. They do not attend daily standups or weekly all-hands. They own the forecast accuracy metric and the win-rate by rep, but they do not own the pipeline generation. Their work is advisory, not operational. The board evaluates them on whether they improved the forecast accuracy from 50% to 70% within 90 days.

A full-time CRO operates on a "command and control" cadence. They are in the office five days a week, running daily standups, weekly pipeline reviews, and monthly forecast calls with the board. They own the entire revenue engine, including marketing, sales development, and customer success. They evaluate every rep’s activity data and demand weekly call recordings. Their first 90 days include firing the bottom 20% of the sales team and replacing them with hires from their network. The board evaluates them on whether they grew the pipeline by 30% and closed at least one strategic deal within the first quarter. The full-time CRO’s compensation is tied to net revenue retention and EBITDA, not just bookings, because the board knows that discounting to hit bookings targets destroys long-term value.

The Signals to Convert or Not Convert

The board should convert a fractional CRO to full-time if, after 90 days, the fractional leader has identified that the company’s sales problem is structural, not tactical. Structural problems include a compensation plan that rewards activity over outcomes, a sales process that has no qualification stage, or a customer success team that is incentivized to churn customers to reduce workload. Tactical problems include poor CRM hygiene, a weak lead generation process, or a VP of Sales who is a micromanager. If the problem is tactical, the fractional CRO can fix it in 90 days and leave. If the problem is structural, the board needs a full-time CRO who can oversee the 12-month implementation of a new compensation plan and a new sales process.

The board should not convert if the fractional CRO’s work has revealed that the CEO is the primary obstacle to the turnaround. A full-time CRO will either be fired by the CEO within six months or will leave because the CEO refuses to delegate. In that case, the board should replace the CEO before hiring a full-time CRO. Another signal not to convert is if the company’s product-market fit is broken, not the sales process. A full-time CRO cannot sell a product that no one wants. The board should invest in product development and keep a fractional CRO who can manage the sales team while the product is rebuilt. If the company’s sales cycle is under 60 days and the team is small (under 10 reps), a full-time CRO is overkill. A fractional leader who works 20 hours per week can manage the team effectively, and the board saves $200,000 per year in salary and benefits.

FAQ

Should the board always hire a full-time CRO if the company has over $20 million in revenue? No, revenue size is not the primary factor. A $20 million company with a 60-day sales cycle and a strong VP of Sales may only need a fractional CRO to refine the pricing model and improve forecast accuracy. A $10 million company with a 180-day sales cycle and a weak VP of Sales may desperately need a full-time CRO to rebuild the sales process and the team. The board should base the decision on the sales cycle length, the CEO’s sales acumen, and the cash runway, not the revenue threshold.

What happens if the full-time CRO fails to deliver a turnaround within six months? The board will likely fire the CRO, but the damage is worse than the firing. The full-time CRO will have fired half the sales team, restructured the compensation plan, and alienated the existing customer base with aggressive discounting. The company will be in a worse position than before, with a demoralized sales team and a churn wave. The board should build a 12-month performance clause into the CRO’s contract, with a 90-day notice period, so the CRO cannot be fired without a transition plan. The board should also hire a fractional CRO as a backup to ensure continuity if the full-time CRO fails.

Can a fractional CRO effectively manage a sales team of 20 reps? Yes, but only if the fractional CRO has a strong VP of Sales who handles day-to-day management. A fractional CRO working 15 hours per week cannot coach 20 individual reps or run daily standups. They can, however, design the compensation plan, audit the pipeline, and coach the VP of Sales on how to manage the team. The board should ensure the VP of Sales has at least five years of management experience and a track record of hitting quotas. If the VP of Sales is weak, the fractional CRO will fail, and the board should hire a full-time CRO instead.

How does the board protect itself from a CRO who over-discounts to hit short-term targets? The board must tie the CRO’s compensation to net revenue retention and gross margin, not just bookings. The CRO should have a clawback clause in their contract that reduces their bonus if the churn rate exceeds 10% within 12 months of their start date. The board should also require the CRO to present a pricing and discounting policy that the board approves before the CRO can close any deals. The CRO should not have unilateral authority to discount beyond 15% without board approval. This forces the CRO to focus on value-based selling rather than price concessions.

Sources